Copper-iodide nanoparticles have long-lasting antiviral activity against the 2009 pandemic H1N1 influenza virus, according to a paper in the February issue of the journal Applied and Environmental Microbiology.
The copper iodide generates reactive oxygen species which kill viruses by degrading viral proteins. The particles can be applied to products such as filters, face masks, kitchen cloths, countertops, and other products where people might come into contact with virus particles, says first author Yoshie Fujimori of NBC Meshtec, Inc., Tokyo, Japan. This is the first demonstration of antiviral activity in copper-iodide nanoparticles.
"Copper-iodide has antiviral activity against other viruses, and antibacterial activity as well," says Fujimori. "We have already sold some products, such as face masks, disposable protective clothing, antiviral sheets and blankets, and bannisters."
Copper has long been known to have antibacterial activity, and several copper compounds had previously been found to have antiviral activity, against both avian influenza virus and human immunodeficiency virus. But the colors of copper metal and copper oxide would have altered the appearance of any products to which they might be applied, while the white copper iodide nanoparticles would not have done so, says Fujimori.
Copper iodide nanoparticles are stable in air and water, which accounts for their long-lasting antiviral activity, whereas the commonly used alcohol hand-sanitizers are relatively ineffective against viruses.
The researchers showed that copper-iodide degrades functional proteins, and they suspect that it does so by generating so-called reactive oxygen species, which are known to degrade proteins. A major advantage of this mechanism is that it would be extremely difficult for a virus to develop resistance to this mechanism, says Fujimori.
Reference: Y. Fujimori, T. Sato, T. Hayata, T. Nagao, M. Nakayama, T. Nakayama, R. Sugamata, and K. Suzuki, 2012. Novel antiviral characteristics of nanosized copper(I) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus. Appl. Environ. Microbiol. 78:951-955.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.